Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for secondary osteoporosis in children with ALL
NCT01656512Phase 3Completed
- Sponsor
- Children's Cancer Hospital Egypt 57357
- Start
- Oct 2011
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in osteoporosis, sponsored by Children's Cancer Hospital Egypt 57357. Started Oct 2011; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT01656512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01656512.